drugset / Trial / NCT01614132

Multicenter Pilot-study for the Therapy of Medulloblastoma of Adults

NCT01614132

Phase 1/2 Completed 33 enrolled University of Regensburg
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether a combination of a radiochemotherapy (vincristin) and a following maintenance chemotherapy (vincristin, cisplatin and CCNU) in adult patients with medulloblastoma is tolerable.

Timeline

Start
2009-01
Primary completion
2018-10
Completion
2018-10

Drugs

EvaluationDrugModalityDoseRoute
Subject CCNU: Lomustin L01AD02 Unknown 75 mg/m2 Oral
Subject Cisplatin Other / unclassified 70 mg/m2 Intravenous
Subject Vincristine Small molecule 2 mg/m2 Intravenous

Indications